J.P. Morgan Downgrades Smith & Nephew (SNN) to Underweight
More News related to SNN
- Piper Jaffray Assumes Smith & Nephew (SNN) and Upgades to Buy
- Cowen Downgrades Smith & Nephew (SNN) to Neutral
- Smith & Nephew Plc - Notice of Results
- Smith and Nephew - appoints Non-Executive Director
- Cramer Backs Up the Truck on Smith & Nephew (SNN)
More News related to Downgrades
- Buckingham Research Reinstates Coverage on Family Dollar (FDO) with an Underperform
- Sidoti Downgrades First Place Financial (FPFC) to Neutral
- ARGUS Downgrades Foundry Networks (FDRY) to Sell
- ARGUS Downgrades Lexmark International (LXK) to Hold
- Jefferies Downgrades BJ's Wholesale (BJ) to Hold
J.P. Morgan downgrades Smith & Nephew (NYSE: SNN) from Neutral to Underweight.
Smith & Nephew plc is a global medical devices company engaged in the development, manufacture and marketing of medical devices in the sectors of orthopedic reconstruction, orthopedic trauma and clinical therapies, endoscopy and advanced wound management.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
